Low dose amiodarone causing pseudo-alcoholic cirrhosis

Age and Ageing

Volumn 32, Issue 2, 2003, Pages 224-225

  Singhal, Amitalh ^a   Ghosh, Partha ^b   Khan, Shahid Anis ^b  

^a BRADFORD ROYAL INFIRMARY   (United Kingdom)

^b LISTER HOSPITAL   (United Kingdom)

Author keywords

Amiodarone; Cirrhosis

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ATORVASTATIN; FUROSEMIDE; RANITIDINE; THYROXINE;

ACUTE HEPATITIS; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CHOLESTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG WITHDRAWAL; HEART ARRHYTHMIA; HEPATOMEGALY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TOXICITY; MALE; PRIORITY JOURNAL;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; MALE;

EID: 0037344494     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/32.2.224     Document Type: Article

References (9)

1. Flaharty KK, Chase SL, Yaghsezian HM, Rubin R. Hepatotoxicity associated with amiodarone therapy. Pharmacotherapy 1989; 9: 39-44.
2. Rumessen JJ. Hepatotoxicity of amiodarone. Acta Med Scand 1986; 219: 235-9.
3. Lewis JH, Ranard RC, Caruso A et al. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology 1989; 9: 679-85.
4. Simon JB, Manlev PN, Brien JF, Armstrong PW. Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med 1984; 11: 167-72.
5. Lewis JH, Ranard RC, Mullick F et al. Histopathologic analysis of suspected amiodarone hepatotoxicity. Hum Pathol 1990; 21: 59-67.
6. Guigui B, Perrot S, Berry JB et al. Amiodarone induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease. Hepatology 1988; 8: 1063-8.
7. Jones WP, Shin MS, Stanley RJ, Duncan-Meyers J. Dense liver in a 72 year old woman with congestive heart failure. Invest Radiol 1985; 20: 911-5.
8. Babany G, Mallat A, Zafrani ES et al. Chronic liver disease after low daily doses of amiodarone. Report of three cases. J Hepatol 1986; 3: 228-32.
9. Tisdale JE, Follin SL, Ordelova A, Webb CR. Risk factors for development of specific noncardiovascular adverse effects associated with amiodarone. J Clin Pharmacol 1995; 35: 351-6.